Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury

被引：0
|
作者：
Heikrujam Nilkanta Meitei
Anupama Pandey
Reena Haobam
机构：
[1] Manipur University,Department of Biotechnology
来源：
Molecular Biology Reports | 2023年 / 50卷
关键词：
AT-DILI; Polymorphisms; Drug metabolism genes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2893 / 2900
页数：7
相关论文
共 50 条
  • [21] A nomogram model to predict the risk of drug-induced liver injury in patients receiving anti-tuberculosis treatment
    Ji, Songjun
    Lu, Bin
    Pan, Xinling
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [22] Association between Genetic Polymorphisms of Drug-metabolizing Enzymes and Transporters and Anti-tuberculosis Drug-induced Liver Injury in a Chinese Population
    Chen, Ru
    Wang, Jing
    Tang, Shaowen
    Zhang, Yuan
    Lv, Xiaozhen
    Zhan, Siyan
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 193 - 194
  • [23] Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
    Wanvisa Udomsinprasert
    Noppadol Chanhom
    Supharat Suvichapanich
    Sukanya Wattanapokayakit
    Surakameth Mahasirimongkol
    Wasun Chantratita
    Jiraphun Jittikoon
    [J]. Scientific Reports, 10
  • [24] Efficacy and safety of bicyclol for treating patients with anti-tuberculosis drug-induced liver injury
    Du, Y.
    Gu, J.
    Yang, Y.
    Chen, Y.
    Wang, Y.
    Mei, Z.
    Li, Y.
    Li, L.
    Xue, D.
    Wang, X.
    Li, D.
    Hu, P.
    Nie, W.
    Chu, N.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2024, 28 (01) : 6 - 12
  • [25] Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
    Wang, Ming-Gui
    Wu, Shou-Quan
    Zhang, Meng-Meng
    He, Jian-Qing
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
    Udomsinprasert, Wanvisa
    Chanhom, Noppadol
    Suvichapanich, Supharat
    Wattanapokayakit, Sukanya
    Mahasirimongkol, Surakameth
    Chantratita, Wasun
    Jittikoon, Jiraphun
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Development of a prediction system for anti-tuberculosis drug-induced liver injury in Japanese patients
    Mushiroda T.
    Yanai H.
    Yoshiyama T.
    Sasaki Y.
    Okumura M.
    Ogata H.
    Tokunaga K.
    [J]. Human Genome Variation, 3 (1)
  • [28] Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy’s Law
    Xin Shen
    Zheng’an Yuan
    Jian Mei
    Zurong Zhang
    Juntao Guo
    Zheyuan Wu
    Jie Wu
    Haihua Zhang
    Jieping Pan
    Wenming Huang
    Huili Gong
    Dong Yuan
    Ping Xiao
    Yanqin Wang
    Yi Shuai
    Senlin Lin
    Qichao Pan
    Tong Zhou
    Paul B. Watkins
    Fan Wu
    [J]. Drug Safety, 2014, 37 : 43 - 51
  • [29] Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study
    Zhao, Hong
    Wang, Yanbing
    Zhang, Ting
    Wang, Qi
    Xie, Wen
    [J]. MEDICAL SCIENCE MONITOR, 2020, 26
  • [30] Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy's Law
    Shen, Xin
    Yuan, Zheng'an
    Mei, Jian
    Zhang, Zurong
    Guo, Juntao
    Wu, Zheyuan
    Wu, Jie
    Zhang, Haihua
    Pan, Jieping
    Huang, Wenming
    Gong, Huili
    Yuan, Dong
    Xiao, Ping
    Wang, Yanqin
    Shuai, Yi
    Lin, Senlin
    Pan, Qichao
    Zhou, Tong
    Watkins, Paul B.
    Wu, Fan
    [J]. DRUG SAFETY, 2014, 37 (01) : 43 - 51
12345